Home
MyCare - Patients: View your medical records securely online here.
Log in Learn More

Hematology

« Previous 12 Next »
Viewing Page 1 of 2 | Showing Results 1 - 10 of 13
Primary or Salvage Immune Tolerance Induction in Patients with Hemophilia A with Inhibitors Utilizing Alphanate®, Factor VIII/ von Willebrand Factor Complex (Human)
Peter Kouides, MD

Retrospective chart review study: Evaluate the rates of success, partial success and failure among hemophilia patients with inhibitors who received...

Improved Susceptometry to Measure Body Iron Studies
Pradyumna Phatak, MD

To confirm that a new -room temperature susceptometer is more sensitive than existing liver susceptometers and is better at overcoming the...

Hemophilia Inhibitor Genetics Study (HIGS)
Peter Kouides, MD

To explore the genetics of Inhibitors in severe hemophiliacs and their families.

Genetic Analysis of Individuals with Non-HFE Familial Hemochromatosis
Ronald Sham, MD

To evaluate families with non-HFE hemochromatosis to determine how two recently discovered proteins – hepcidin and hemojuvelin – play a role in...

The Role of Hepcidin and Hemojuvelin in Iron Regulation (UCLA Study)
Pradyumna Phatak, MD

To evaluate families with non-HFE hemochromatosis to determine how two recently discovered proteins – hepcidin and hemojuvelin – play a role in...

Study of von Willebrand factor level in women after childbirth
Peter Kouides, MD

To provide data that will guide providers in determining the optimal duration of prophylaxis for women with VWD after delivery.

Fine point mapping inhibitor epitopes in factor VIII
Ronald Sham, MD

To explore the genetics of FVIII in inhibitors through gene mapping

A Consumer Survey: National Hemophilia Foundation National Prevention Program
Peter Kouides, MD

To collect data from survey to evaluate NHF's National Prevention Program (NPP)

The VWD International Prophylaxis (VIP) Study
Peter Kouides, MD

To study the safety and efficacy of prophylaxis on bleeding episodes, QOL in prophylaxis, clinical manifestations of prophylaxis vs. no prophylaxis.

The Molecular and Clinical Biology of von Willebrand Disease
Peter Kouides, MD

To Identify mutations in the VWF gene associated with the type1 or 3 VWD and correlate these with a clinical bleeding assessment; to identify...

« Previous 12 Next »